AM-Pharma completes Phase II enrollment of recAP in AKI

AM-Pharma B.V. (Bunnik, the Netherlands) completed enrollment of 301 patients in the Phase II

Read the full 141 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE